Preferred Name |
DAUNORUBICIN CITRATE LIPOSOME |
|
Synonyms |
|
|
ID |
http://purl.bioontology.org/ontology/NDFRT/N0000148439 |
|
Contraindicated with disease |
http://purl.bioontology.org/ontology/NDFRT/N0000010195 http://purl.bioontology.org/ontology/NDFRT/N0000000469 http://purl.bioontology.org/ontology/NDFRT/N0000002291 http://purl.bioontology.org/ontology/NDFRT/N0000002932 http://purl.bioontology.org/ontology/NDFRT/N0000000999 |
|
cui |
C0724567 |
|
FDA UNII Code |
5L84T2Z6NP |
|
Has ingredient | ||
Has mechanism of action | ||
Has physiologic effect |
http://purl.bioontology.org/ontology/NDFRT/N0000008576 |
|
LEVEL |
Ingredient |
|
May treat |
http://purl.bioontology.org/ontology/NDFRT/N0000002676 http://purl.bioontology.org/ontology/NDFRT/N0000003267 |
|
NDFRT kind |
DRUG_KIND |
|
notation |
N0000148439 |
|
NUI |
N0000148439 |
|
prefLabel |
DAUNORUBICIN CITRATE LIPOSOME |
|
Product component of | ||
tui |
T109 T195 |
|
VANDF RECORD |
50.416^3632^Active/Master |
|
VUID |
4020966 |
|
subClassOf |
Create mapping